Granite Point Capital Management, L.P. Vericel Corp Transaction History
Granite Point Capital Management, L.P.
- $0
- Q3 2023
Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
267Shares Held
48.9MCall Options Held
150KPut Options Held
128K-
Black Rock Inc. New York, NY7.97MShares$399 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.95MShares$248 Million4.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$171 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$161 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.33MShares$117 Million1.77% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.36B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...